Skip to main content

Genprex, Inc.

GNPX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001595248

No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Genprex, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of GNPX: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders4750+3
Shares7.46M4.78M−2.68M (−35.9%)
Value$9.78M$10.8M+$1.02M (+10.4%)

New holders (12)

Institutions that held Genprex, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to GNPX in Q1 2022
InstitutionSharesValue% of portfolio
Verus Capital Partners, LLC85,500$193.0K0.03%
Charles Schwab Investment Management Inc29,742$68.0K0.00%
Cubist Systematic Strategies, LLC19,950$45.0K0.00%
TCG Advisory Services, LLC16,000$36.0K0.01%
Susquehanna Fundamental Investments, LLC13,001$29.0K0.00%
Jane Street Group, LLC12,200$28.0K0.00%
HighTower Advisors, LLC11,179$25.0K0.00%
Meeder Asset Management Inc10,676$23.0K0.00%
FMR LLC2,168$5.00K0.00%
Citigroup Inc1,800$4.00K0.00%
Glassman Wealth Services1$00.00%
IFP Advisors, Inc4,000––

Sold out (9)

Institutions that held Genprex, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of GNPX in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Renaissance Technologies LLC903,400$1.18M
Anson Funds Management LP438,874$575.0K
D. E. Shaw & Co., Inc.125,234$164.0K
Susquehanna International Group, LLP116,304$152.0K
Two Sigma Investments, LP72,290$95.0K
Two Sigma Securities, LLC31,737$42.0K
Resources Investment Advisors, LLC.13,250$17.0K
ExodusPoint Capital Management, LP11,900$16.0K
Eaton Vance Management5$0